Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.

NCT05567458 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Β-Thalassemia Treatment with KL003 Cell Injection

NCT06280378 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.

NCT05860595 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study of Effects of YisuiShengxueGranules on Thalassemia

NCT01549080 ·Status: COMPLETED

Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia

NCT01709838 ·Status: COMPLETED ·Phase: PHASE4

A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]

NCT05762510 ·Status: RECRUITING ·Phase: EARLY_PHASE1

An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old

NCT01724138 ·Status: WITHDRAWN ·Phase: PHASE4

Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.

NCT06655662 ·Status: RECRUITING ·Phase: PHASE1

A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants

NCT05757245 ·Status: RECRUITING ·Phase: PHASE1

A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

NCT06024876 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major

NCT06291961 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia

NCT06734520 ·Status: RECRUITING ·Phase: NA

the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia

NCT05851105 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector

NCT03351829 ·Status: UNKNOWN ·Phase: NA

A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

NCT00171171 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)

NCT01996683 ·Status: UNKNOWN ·Phase: NA

A Long-term Follow-up Study in Participants Who Received CS-101

NCT06685536 ·Status: ENROLLING_BY_INVITATION

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

NCT00560820 ·Status: COMPLETED ·Phase: PHASE1

Long-term Follow-up Study of BRL-101 for TDT

NCT06298630 ·Status: NOT_YET_RECRUITING

Iron Status in BTM With Blood Transfusion

NCT04947540 ·Status: UNKNOWN

Long-term Follow-up Study of BHC001 for TDT

NCT06314529 ·Status: RECRUITING

Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients

NCT02198508 ·Status: COMPLETED ·Phase: NA

the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia

NCT05864170 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

NCT05577312 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone

NCT00000588 ·Status: COMPLETED ·Phase: PHASE2